Table S5 from Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy
Laura M. Rogers(University of Iowa), George J. Weiner(University of Iowa), Sarah L. Mott(University of Iowa), Brian K. Link(University of Iowa), Deniz Şahin(Roche (Switzerland))
Cited by 0
Related Papers
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274
Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study
|BJOG An International Journal of Obstetrics & Gynaecology|1995|215
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
|Nature Genetics|2013|211
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190